The French Gaucher’s disease registry: clinical characteristics, complications and treatment of 562 patients
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The French Gaucher’s disease registry: clinical characteristics, complications and treatment of 562 patients
Authors
Keywords
-
Journal
Orphanet Journal of Rare Diseases
Volume 7, Issue 1, Pages 77
Publisher
Springer Nature
Online
2012-10-10
DOI
10.1186/1750-1172-7-77
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula
- (2012) Pilar Giraldo et al. Orphanet Journal of Rare Diseases
- Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience
- (2010) A. Zimran et al. BLOOD
- Osteopenia in Gaucher disease develops early in life: Response to imiglucerase enzyme therapy in children, adolescents and adults
- (2010) Pramod K. Mistry et al. BLOOD CELLS MOLECULES AND DISEASES
- The incidence of Parkinsonism in patients with type 1 Gaucher disease: Data from the ICGG Gaucher Registry
- (2010) Barry Rosenbloom et al. BLOOD CELLS MOLECULES AND DISEASES
- The risk of Parkinson’s disease in type 1 Gaucher disease
- (2010) Gilberto Bultron et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry
- (2010) Anna Tylki-Szymańska et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Bone events and evolution of biologic markers in Gaucher disease before and during treatment
- (2010) Jerome Stirnemann et al. ARTHRITIS RESEARCH & THERAPY
- Gaucher disease and monoclonal gammopathy: A report of 17 cases and impact of therapy
- (2009) Bernard Grosbois et al. BLOOD CELLS MOLECULES AND DISEASES
- Force Majeure: Therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease
- (2009) Carla E.M. Hollak et al. BLOOD CELLS MOLECULES AND DISEASES
- Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis
- (2009) Pramod K. Mistry et al. BRITISH JOURNAL OF HAEMATOLOGY
- Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study
- (2009) KB Sims et al. CLINICAL GENETICS
- Parkinsonism in Gaucher's disease type 1: Ten new cases and a review of the literature
- (2009) Ichraf Kraoua et al. MOVEMENT DISORDERS
- Lysosomal Storage Disorders in the Newborn
- (2009) O. Staretz-Chacham et al. PEDIATRICS
- A benchmark analysis of the achievement of therapeutic goals for type 1 Gaucher disease patients treated with imiglucerase
- (2008) Neal Weinreb et al. AMERICAN JOURNAL OF HEMATOLOGY
- Life expectancy in Gaucher disease type 1
- (2008) Neal J. Weinreb et al. AMERICAN JOURNAL OF HEMATOLOGY
- Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature
- (2008) M. de Fost et al. ANNALS OF HEMATOLOGY
- Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: An analysis of 798 patients from the ICGG Gaucher Registry
- (2008) C. Fairley et al. JOURNAL OF INHERITED METABOLIC DISEASE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started